Using a digital score (+ to ++++), we identified a tendency towards increased intensity of OB-Rb expression in type I ovarian cancers compared with the benign lesions (Figure 2A, * represents benign lesions, ** represents borderline or type I cancer). This evidence concerns the gene RB1 and ovarian cancer.